Literature DB >> 17198246

A highly efficient living donor kidney exchange program for both blood type and crossmatch incompatible donor-recipient combinations.

Marry de Klerk1, Marian D Witvliet, Bernadette J J M Haase-Kromwijk, Frans H J Claas, Willem Weimar.   

Abstract

BACKGROUND: Lack of deceased donors for kidney transplant patients in the Netherlands encouraged alternative options to expand the living donor pool for recipients who have a willing donor but cannot donate directly because of a positive crossmatch or ABO blood type incompatibility. A national donor kidney exchange was considered as a possible solution.
METHODS: From January 2004 until June 2006, 146 couples from seven kidney transplantation centers were enrolled and participated in 10 match procedures. The Dutch Transplant Foundation was responsible for the allocation and the National Reference Laboratory for Histocompatibility in Leiden performed all the serological crossmatches.
RESULTS: For 72 out of the 146 (49%) donor-recipient combinations, a match was found. The success rate in the positive crossmatch group was significantly (P = 0.0015) higher than in the ABO-incompatible group (44/69 vs. 28/77); median panel reactive antibodies of the matched recipients in the positive crossmatch group was 38% (0-100) and in the ABO-incompatible group 0% (0-27; P < 0.001). We were least successful for ABO blood type incompatible pairs with blood type O recipients, but for 9/53 (17%) there were possibilities. These nine blood type incompatible pairs were coupled to nine positive crossmatch pairs, which reflects the efficiency of combining the two categories of donor-recipient combinations into one program.
CONCLUSION: The donor kidney exchange program in the Netherlands, in which all seven kidney transplantation centers participated, proved to be a successful program to expand the number of living donor kidney transplantations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17198246     DOI: 10.1097/01.tp.0000250906.66728.8d

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  6 in total

Review 1.  Immunohaematological and apheretic aspects of the first kidney transplant from a living, ABO-incompatible donor carried out in Italy.

Authors:  Maria Sassi; Umberto Maggiore; Carlo Buzio; Massimo Franchini
Journal:  Blood Transfus       Date:  2010-11-26       Impact factor: 3.443

2.  Virtual Crossmatching in Kidney Transplantation, Shiraz Experience in Development of a Web-Based Program.

Authors:  N Jamshidian Tehrani; B Geramizadeh; S A Malekhosseini; S Nikeghbalian; A Bahador; S Gholami; G A Raees Jalali; J Roozbeh; M H Anbardar; N Soleimani; N Rasaei; S Mohammadzadeh
Journal:  Int J Organ Transplant Med       Date:  2021

3.  ABO-Incompatible Kidney Transplant Outcomes: A Meta-Analysis.

Authors:  Annelies E de Weerd; Michiel G H Betjes
Journal:  Clin J Am Soc Nephrol       Date:  2018-07-16       Impact factor: 8.237

4.  Kidney Exchange Program Reporting Standards: Evidence-Based Consensus From Europe.

Authors:  Bart Smeulders; Michal A Mankowski; Joris van de Klundert
Journal:  Front Public Health       Date:  2021-02-11

5.  Kidney transplantation in sensitized recipients; a single center experience.

Authors:  Sun Moon Kim; Chungsik Lee; Jung Pyo Lee; Eun Man Kim; Jongwon Ha; Sang Joon Kim; Myoung Hee Park; Curie Ahn; Yon Su Kim
Journal:  J Korean Med Sci       Date:  2009-01-28       Impact factor: 2.153

6.  Building Kidney Exchange Programmes in Europe-An Overview of Exchange Practice and Activities.

Authors:  Péter Biró; Bernadette Haase-Kromwijk; Tommy Andersson; Eyjólfur Ingi Ásgeirsson; Tatiana Baltesová; Ioannis Boletis; Catarina Bolotinha; Gregor Bond; Georg Böhmig; Lisa Burnapp; Katarína Cechlárová; Paola Di Ciaccio; Jiri Fronek; Karine Hadaya; Aline Hemke; Christian Jacquelinet; Rachel Johnson; Rafal Kieszek; Dirk R Kuypers; Ruthanne Leishman; Marie-Alice Macher; David Manlove; Georgia Menoudakou; Mikko Salonen; Bart Smeulders; Vito Sparacino; Frits C R Spieksma; María Oliva Valentín; Nic Wilson; Joris van der Klundert
Journal:  Transplantation       Date:  2019-07       Impact factor: 4.939

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.